|
|
|
| Developing new delivery routes for biological therapies is essential for creating more patient-centric and effective treatments. By using nanoforming techniques, it's possible to simplify dosing regimens and enhance patient comfort, compliance, and even reduce overall healthcare costs. Find out how this is best demonstrated through two real-world examples. Learn more |
|
|
|
A Companion Diagnostic Strategy For Combination Products | By Marcelo Trevino, independent expert | In the United States, the Office of Combination Products assigns primary jurisdiction for in vitro diagnostics (CDER, CBER, or CDRH). This article shares regulatory and commercial considerations. |
|
|
|
By Drug Delivery Leader: In Combinarion | This episode of In Combination offers considerations around supplier relationships in product development for combination products and other delivery devices. These include quality management, documentation, usability testing, regulatory pathways, post-market design changes, and other aspects of supplier controls. | |
|
|
|
|
| Layer By Layer: 3D Screen Printing And The Future Of Drug Development | Article | By Steven Facer, Adare Pharma Solutions and Klaus Kuhne, Laxxon Medical | 3D screen printing can produce tablets across a range of release profiles, from conventional immediate release tablets to multi-compartment drug delivery systems that mix different release profiles. |
|
|
|
|
|
| Computational Modeling Of Injection-Related Tissue Responses | Article | By Olivia Jefferies, Elizabeth Margerison, and Asmita Khanolkar, SMC Ltd. | Optimizing delivery along with the formulation is the key to successful clinical outcomes. Research is necessary to understand the relationship between body morphology, injection force, and needle length. |
|
|
|
|
|
|
|
.png){kind=logo}
